Dysfunctional Drug Discount Programs Risk Harming Patients They Are Meant to Help
By Dr. Gavin Magaha PharmD MS – The current turmoil surrounding the 340B Drug Pricing Program and Medicaid Drug Rebate Program. Bloomberg Law, recently reported that pharmaceutical manufacturers and a trade organization have filed at least 23 that extend 340B drug discounts to an unlimited number of contract pharmacies.
Read More